Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular characterization of acquired enrofloxacin resistance in Mycoplasma synoviae field isolates.

Antimicrobial agents and chemotherapy - 1 Jul 2013

Lysnyansky I, Gerchman I, Mikula I, Gobbo F, Catania S, Levisohn S

Abstract excerpt

The in vitro activity of enrofloxacin against 73 Mycoplasma synoviae field strains isolated in Israel and Europe was determined by broth microdilution. Decreased susceptibility to enrofloxacin was identified in 59% of strains, with the MICs ranging from 1 to >16 μg/ml. The estimated MIC50 and MIC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Gyrase
Share to DNA Topoisomerase IV
Share to Fluoroquinolones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Israel

Share to Lectins

Share to Molecular Typing

Share to Mycoplasma Infections

Share to Quinolones

Source

Open in PubMed Open full text

Identifiers

PMID: 23612192
DOI: 10.1128/AAC.00203-13
PMCID: PMC3697329

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23612192-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular characterization of acquired enrofloxacin resistance in Mycoplasma synoviae field isolates.PMID 23612192Read ↗

Mutations potentially associated with decreased susceptibility to fluoroquinolones, macrolides and lincomycin in Mycoplasma synoviae.Semantic proximity Read ↗

Development of molecular assays for the rapid and cost-effective determination of fluoroquinolone, macrolide and lincosamide susceptibility of Mycoplasma synoviae isolates.Semantic proximity Read ↗

Persistence of Mycoplasma synoviae in hens after two enrofloxacin treatments and detection of mutations in the parC gene.Semantic proximity Read ↗

The Spread of Mycoplasma pneumoniae Is Polyclonal in Both an Endemic Setting in France and in an Epidemic Setting in IsraelSemantic proximity Read ↗

Multi-locus sequence typing analysis of Mycoplasma synoviae isolates reveals unique sequence types in China.Semantic proximity Read ↗

Antimicrobial Resistance in Mycoplasma sppSemantic proximity Read ↗

Development and evaluation of a multi-locus sequence typing scheme for Mycoplasma synoviae.Semantic proximity Read ↗

Molecular typing of Iranian field isolates Mycoplasma synoviae and their differentiation from the live commercial vaccine strain MS-H using vlhA gene.Semantic proximity Read ↗

Molecular characterization of enrofloxacin resistant Actinobacillus pleuropneumoniae isolates.Semantic proximity Read ↗

Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental modelsSemantic proximity Read ↗

Epidemiological investigations and locally determined genotype diversity of Mycoplasma synoviae in Central China from 2017 to 2019.Semantic proximity Read ↗

Multilocus sequence analysis for Mycoplasma synoviae molecular genotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.